FDA
-
-
-
-
-
-
-
DiaMedica raises $30 million to fund preeclampsia drug development
-
-
-
-
-
-
-
DiaMedica Therapeutics Announces Formation of Scientific Advisor Board to Support the Development of DM199 for the Treatment of Preeclampsia
-
-
-
-
-
-
-
DiaMedica Therapeutics (DMAC) Announces Closing of $11.8 Million Private Placement
-
-
-
-
-
-
-
DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2023 Financial Results
-
-
-
-
-
-
-
DiaMedica Therapeutics Announces Closing of $37.5 Million Private Placement
-
-
-
-
-
-
-
DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2023 Financial Results
-
-
-
-
-
-
-
DiaMedica Therapeutics Appoints Julie Daves as SVP, Clinical Development Operations
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

